Government Backs MedTech as a Strategic Sector, Aims for $30 Billion Market by 2030 India to Expand Global MedTech Share to 10-12% by 2030 – Union Minister of State
National Desk,New Delhi, January 31st 2025:MedTekon 2025, the flagship event of the Medical Technology Association of India (MTaI), brought together policymakers, global dignitaries, investors, and healthcare leaders at Taj Palace, New Delhi. With a core focus on Investments, Reforms, and Synergies, the event aimed to accelerate policy advancements, boost investments, and drive technological innovations in India’s MedTech sector.
India’s MedTech Growth Vision
Speaking at the event, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers emphasized:
“It is an honor to inaugurate MedTekon 2025, a platform uniting industry leaders, policymakers, and healthcare stakeholders to shape the future of India’s MedTech sector. With the industry projected to double its market size to $30 billion by 2030 and expand its global share from 1.65% to 10-12%, India is rapidly emerging as a MedTech powerhouse. Our exports reached $3.8 billion last year, demonstrating the sector’s growing manufacturing strength and global competitiveness. As we drive this momentum forward, collaborative efforts in innovation, investment, and policy reforms will be crucial in positioning India as a leader in affordable, high-quality medical technology.”
Dr. V. K. Paul, Member, NITI Aayog, while addressing the session on Catalyzing Foreign & Domestic Investments in MedTech, highlighted:
“MedTekon 2025 is a vital platform to expand India’s global footprint, foster innovation, and strengthen domestic manufacturing. With the rising demand for medical devices, India must strategically position itself as a global MedTech leader. More than 4,000 health-tech startups in India need greater investment, regulatory support, and structured incubation to scale globally. Additionally, harmonizing regulatory standards with global benchmarks is essential for investor confidence and sectoral growth. By prioritizing innovation, investment, and policy stability, India can solidify its position as a leader in affordable, cutting-edge medical technology.”
Industry Leaders Call for Investment-Friendly Policies
Pavan Choudary, Chairman, MTaI, stressed the importance of investment-friendly policies, regulatory coherence, and a strong MedTech infrastructure to support India’s growing healthcare needs.
“At MTaI, we believe that sharp advocacy stems from thoughtful deliberation, and MedTekon 2025 embodies this commitment,” he said.
On a thought-provoking note, when asked if technology was responsible for dehumanization and increased stress, Pavan Choudary disagreed and remarked:
“The rise of Hikikomori (a term used in Japan for people who prefer technology-driven interactions over human engagement) shows that human interactions can sometimes lead to stress and distress. Machines don’t judge and don’t tire, making them preferable to many millions of Hikikomoris worldwide—whose numbers continue to rise.”
Key Speakers & Global Participation
MedTekon 2025 featured a distinguished panel of Indian and global MedTech leaders, including:
Aseem Sahu – Deputy Drugs Controller, CDSCO
Ajit Chavan – Additional CEO, GeM
Ritu Sain – Investment Commissioner, Government of Chhattisgarh
Hitendra Sahu – Director, Department of Pharmaceuticals
Chinmai Dwivedi – MHD Head, BIS
Padmashree Dr. Kameshwar Prasad – AIIMS & Fortis Healthcare
Dr. O.P. Yadava – CEO, National Heart Institute
Dr. Pavan Gurha – Head of Department, Anaesthesiology, Batra Hospital
Sanjay Bhutani – MD, Bausch & Lomb India & SAARC
Aman Rishi – VP & GM, Stryker India
Atul Grover – Managing Director, India & South Asia, Becton Dickinson
Parmeshwaran Nair – Country Leader, SEA Region & India, Edwards Lifesciences
The event also saw participation from foreign dignitaries, including:
Dr. Stephan Hesselmann – Minister Counsellor, German Embassy
Estelle David – Trade & Investment Commissioner, French Embassy
Nico Schiettekatte – Counsellor for Health & Welfare, Embassy of the Netherlands
Anna Shotbolt – Deputy Trade Commissioner, South Asia, British High Commission
Key Focus Areas & Discussions
Investment & R&D in MedTech
Discussions on positioning India as a global MedTech manufacturing and R&D hub.
Hospital Technology Integration
Experts examined the impact of AI, robotics, and digital health solutions on patient care.
Reimbursement & Health Insurance Policies
The need for designing health insurance models tailored for emerging medical technologies.
Regulatory Framework & Business Ease
A panel discussion on harmonizing regulatory standards to boost global investor confidence.
Ethical Marketing & Skill Development
Highlighting the importance of transparent marketing and training a future-ready workforce.
MedTekon 2025: Paving the Future of MedTech in India
The event reinforced India’s commitment to healthcare innovation, focusing on investment-led growth, regulatory advancements, and technological breakthroughs.
With MedTech poised to become a $30 billion market by 2030, India is set to capture 10-12% of the global MedTech share, strengthening its position as a key player in healthcare technology.
About Medical Technology Association of India (MTaI)
The Medical Technology Association of India (MTaI) is a premier association in India’s MedTech sector, comprising leading research-based medical technology companies with global expertise in innovation and manufacturing.
MTaI works to enhance access to quality healthcare, advocating for policies that support both patients and the industry. Recognized as a leading think tank in healthcare, MTaI collaborates with the government, healthcare professionals, and other stakeholders to drive cutting-edge research and policy recommendations.
